Skip to main content

AGC Pharma Chemicals will be exhibiting at CPHI Frankfurt 2025, the key global event for pharmaceutical development and manufacturing, from October 28 to 30, 2025.

CPHI brings together the entire pharmaceutical supply chain in one place. Join us at Booth 6.0B44 to learn more about our end-to-end CDMO services across the full life cycle of API process development and manufacturing, including High Potency APIs (HPAPI) up to OEB 5.

We offer development, scale-up, commercial manufacturing, and regulatory support from our facilities in Europe and Japan. Whether you need support for clinical batches or full commercial production, we bring experience, flexibility, and global reach.

Our team will be there to talk about our approach to Delivering Top Pharma Quality. Come meet us and explore how we can support your next project with practical, high-quality solutions.

Learn more: https://www.cphi.com/

Latest News

Events & ConventionsAGC Pharma Chemicals to Attend CPHI Japan 2026
8th April 2026

AGC Pharma Chemicals to Attend CPHI Japan 2026

Meet AGC Pharma Chemicals at CPHI Frankfurt 2025, Booth 6.0B44. Discover how we deliver top pharma quality through our CDMO services for APIs and HPAPIs.
Events & ConventionsAGC Pharma Chemicals Honored in Four Categories at the CDMO Leadership Awards 2026
31st March 2026

AGC Pharma Chemicals Honored in Four Categories at the CDMO Leadership Awards 2026

Best in Class distinctions for Overall Staff, Cultural Fit, Technology Use, and Scaling Support. Recognition within the Small/Mid-Size Small Molecule API group. Barcelona, March 30, 2026 – AGC Pharma Chemicals has…
How Reactors Work in a CDMO for Small Molecule APIsAll of ArticlesCDMO ProcessesCDMO TechnologyHow Reactors Work in a CDMO for Small Molecule APIs
13th March 2026

How Reactors Work in a CDMO for Small Molecule APIs

In a pharmaceutical Contract Development and Manufacturing Organization (CDMO), reactors are the foundational equipment where chemical reactions convert raw materials into intermediates and Active Pharmaceutical Ingredients (APIs) under tightly controlled…